New vaccine aims to tame chronic hepatitis b
NCT ID NCT03038802
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 22 times
Summary
This study tests a new vaccine designed to help the immune system control or possibly cure chronic hepatitis B. About 40 adults with chronic hepatitis B will receive the vaccine to see if it is safe and can lower the virus level in their blood. The goal is to reduce the need for long-term medication.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC HEPATITIS B are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
ARASMI
Adelaide, South Australia, 5046, Australia
Contact
Contact
Conditions
Explore the condition pages connected to this study.